Inflation Reduction Act Contains Important Cost-Saving Changes for Many Patients — Maybe for You
The legislation, which the House is expected to pass Friday, would allow the federal government, for the first time, to negotiate the price of some drugs that Medicare buys. It also would extend the enhanced subsidies for people who buy insurance on the Affordable Care Act marketplaces.
After ‘a Lot of Doors Shut in Our Face,’ Crusading Couple Celebrate Passage of Burn Pit Bill
Le Roy and Rosie Torres founded the Burn Pits 360 group that advocated for years for Congress to help veterans suffering from injuries caused by the massive disposal sites on overseas bases. Le Roy came home from Iraq suffering from breathing problems.
Seeking to Kick-Start Biden’s Agenda, Schumer Unveils a Bill for Medicare Drug Price Negotiations
In addition to allowing federal officials to negotiate the price that Medicare pays for some drugs, the bill would cap annual out-of-pocket drug costs for Medicare beneficiaries at $2,000. But before Democrats can pass the bill under special rules that prevent Republicans from staging a filibuster, they must get approval from the Senate parliamentarian.
Peligran transplantes para niña estadounidense de 11 años por burocracia migratoria
En un caso que refleja las fallas significativas y a menudo desgarradoras del sistema, los Espinosa se enfrentan no solo al complicado y costoso laberinto de la atención médica de la nación, sino también a un sistema de inmigración que el Congreso no ha reformado durante décadas.
Immigration Bureaucracy Threatens 11-Year-Old’s Spot on Transplant Lists
Julia Espinosa is a U.S. citizen who needs high-tech care and three transplants. But if the federal government won’t let her father work here, she could lose her insurance.
Senate GOP Puts Up Roadblocks to Bipartisan House Bill for Veterans’ Burn Pit Care
The Senate could start work this week on a bipartisan bill to make it much easier for veterans to get health care and benefits if they get sick from exposure to massive, open-air incineration pits in war zones. The legislation has gained minimal support among Senate Republicans, who say they are concerned about the cost and the ability of Veterans Affairs to handle such a large new mission.
Insulin Copay Cap Passes House Hurdle, But Senate Looks for a Broader Bill
Sens. Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.) are seeking to craft a compromise that members from both parties could accept. Their plan, still being ironed out, would not guarantee a specific limit on out-of-pocket costs but seeks to roll back insulin prices by barring rebate payments to pharmacy benefit managers.
$35 Insulin Cap Is Welcome, Popular, and Bipartisan. But Congress May Not Pass It Anyway.
Spun off from the ailing but not-quite-dead Build Back Better legislation, a popular proposal to cap out-of-pocket insulin costs at $35 a month faces tough political realities that could kill it.
Plan to Fix Postal Service Shifts New Retirees to Medicare — Along With Billions in Costs
After a years-long bitter partisan fight over reforming the U.S. Postal Service’s finances and service, congressional leaders say they have a compromise. The bill, which has won endorsements from both Republicans and Democrats on Capitol Hill, would force future Postal Service retirees to use Medicare as their primary source of health coverage.
Becerra Says Surprise Billing Rules Force Doctors Who Overcharge to Accept Fair Prices
The Health and Human Services secretary says the administration has heard complaints from doctors and hospitals about the rules it unveiled for implementing the law to end surprise medical bills. But he says providers who have exploited a complicated system to charge exorbitant rates will have to bear their share of the cost — or close.
Congressional Doctors Lead Bipartisan Revolt Over Policy on Surprise Medical Bills
Congress last year shielded consumers from unexpected out-of-network charges, but hospitals and doctors have decried the arbitration plan put forward by the Biden administration for negotiating these bills as favoring insurers. More than 150 members of the House agree.
La nueva legislación bajaría dramáticamente el precio de la insulina, y lograría que el impacto de los precios astronómicos no recaigan en el consumidor.
Despite Restraints, Democrats’ Drug Pricing Plan Could Still Aid Consumers
A last-minute agreement among lawmakers restored a provision seeking to hold down rising costs of prescription medicines. Although details on which drugs will be targeted remain sketchy, the legislation would help patients buying insulin and cap Medicare beneficiaries’ out-of-pocket drug costs at $2,000 a year.
‘Luckiest Man Alive’: Why 9/11 First Responders’ Outlooks May Improve Even as Physical Health Fails
The New York City Fire Department’s 20-year report on the health consequences of the 9/11 terrorist attacks finds that first responders consistently report mental health quality-of-life indicators that are better than those of average Americans, even as their physical health declines.
2+2=? Senate Uses Murky Math as It Shelves Drug Pricing Rule to Fund Infrastructure
The Medicare rule, designed by the Trump administration to take money away from drug industry brokers and provide refunds to patients, has not been implemented. But budget analysts say if it were, it would cost the government money. So senators are pushing the rule aside and claiming to save billions of dollars, which they want to use instead on new projects.
Sen. Wyden: $3.5T Budget May Have to Trim but It Can Set a Path to ‘Ambitious Goals’
Sen. Ron Wyden (D-Ore.), who is helping to negotiate the health care spending framework for the Democrats’ budget plan, said lawmakers may have to settle for very basic versions of programs deployed in the package. But the key, he added, is to get the “architecture of these changes, bold changes,” started and show people what is possible.
Senate Democrats’ Plan Boosts Spending on Medicare, ACA Subsidies, Long-Term Care
The plan from high-wire negotiations would affect five key areas of health, but there will be further tense negotiations among Democratic lawmakers about specifics of the $3.5 trillion in funding. And all Senate Democrats will need to be behind the plan, because Republicans oppose it.
Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
The pharmaceutical industry argues that large profits are needed to fund extensive research and innovation. But Democrats on the House Oversight and Reform Committee, seeking to bolster their effort to let Medicare negotiate drug prices, say major drug companies plow more of their billions in earnings back into propping up their stock and enriching executives and shareholders.
Lady Gaga and J.Lo Sell ‘Well’ Building Seal, But It’s a Payday, Not a PSA
A company sees the pandemic as an opportunity to push its ‘Well’ seal. It would like the indoor wellness logo to become as ubiquitous as the LEED green building halo — and make a profit, too.
Military Exposed to Toxic Fumes From Burn Pits Set to Get Bipartisan Boost
Democratic Sen. Kirsten Gillibrand and Republican Sen. Marco Rubio were set to roll out a bill Friday that could help unknown thousands of service members who are sick from toxic substances they were exposed to from burning garbage in Afghanistan, Iraq and other war zones.
